Peapack-Gladstone Financial Corp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $711K | Sell |
1,596
-181
| -10% | -$80.6K | 0.01% | 431 |
|
|
2025
Q1 | $861K | Sell |
1,777
-408
| -19% | -$198K | 0.01% | 409 |
|
|
2024
Q4 | $879K | Sell |
2,185
-1
| -0% | -$402 | 0.01% | 402 |
|
|
2024
Q3 | $1.02M | Buy |
2,186
+120
| +6% | +$55.8K | 0.01% | 390 |
|
|
2024
Q2 | $968K | Buy |
2,066
+548
| +36% | +$257K | 0.01% | 397 |
|
|
2024
Q1 | $634K | Buy |
1,518
+185
| +14% | +$77.3K | 0.01% | 452 |
|
|
2023
Q4 | $542K | Buy |
1,333
+130
| +11% | +$52.9K | 0.01% | 473 |
|
|
2023
Q3 | $417K | Hold |
1,203
| – | – | 0.01% | 506 |
|
|
2023
Q2 | $423K | Sell |
1,203
-267
| -18% | -$93.9K | 0.01% | 510 |
|
|
2023
Q1 | $463K | Buy |
1,470
+50
| +4% | +$15.7K | 0.01% | 498 |
|
|
2022
Q4 | $410K | Sell |
1,420
-130
| -8% | -$37.5K | 0.01% | 492 |
|
|
2022
Q3 | $449K | Hold |
1,550
| – | – | 0.01% | 472 |
|
|
2022
Q2 | $437K | Hold |
1,550
| – | – | 0.01% | 458 |
|
|
2022
Q1 | $402K | Buy |
1,550
+50
| +3% | +$13K | 0.01% | 505 |
|
|
2021
Q4 | $330K | Hold |
1,500
| – | – | 0.01% | 545 |
|
|
2021
Q3 | $272K | Buy |
+1,500
| New | +$272K | 0.01% | 559 |
|